The Results Are In

Study 1

REFERENCE: Crowell, M.D. & Cheskin L.J, The Johns Hopkins University School of Medicine. Multicenter Evaluation of Health Benefits and Weight Loss on the Medifast Weight Management Program.

PURPOSE: To retrospectively evaluate the efficacy of a medically supervised, protein-supplemented modified fasting program (Medifast) for weight reduction and to evaluate the impact of weight reduction on coexisting health problems.

RESULTS: The results of the study concluded that medically-supervised, protein-sparing modified fasts offer a safe and effective means of weight reduction and are accompanied by significant improvements in coexisting health problems. Of samples taken, males lost an average of 67 lbs and females lost an average of 47 lbs during fasting. The study found significant reductions in systolic and diastolic blood pressure, total cholesterol and triglycerides, as well as the normalizing of blood pressure and hypertensive patients.

Additional Information

Study 2

PURPOSE: To evaluate the efficacy of the standard ADA (American Diabetic Association) self-selected diet (SD) vs. a portion controlled diabetic food diet (PCD) in obese patients with NIDDM. The study also aims to evaluate not only the metabolic effects in the long term, but also compliance and any consequent medication changes in patients of the two weight loss regimens. (16-34 weeks of active weight loss, 52 weeks of maintenance) The meal replacements (Medifast) used in this study are soy-based products (bars, shakes, soups) that are considerably lower in sugar than their non-diabetic counterparts and other popular diet products on the market.
>Read More...

If you place your order right now, you will receive:
· 4 weeks of meals
· a FREE shaker jar
· a FREE week of meals
· the book The Secret is Out ($19.95 value)
· FREE shipping and handling
All for only $275
>Order This Plan Now..

Still Not Sure?
If you're still not sure, and you'd like to just try it, perhaps our 2 Week Meal Package is right for you.
>Order This Plan Now..

Study 3

PURPOSE: The study examined whether women on a weight loss program who are carriers of a genetic variant (Trp64Arg) lose less visceral fat than women who do not have this gene. Participants entered a medically supervised weight loss program aimed at reducing body weight to less than 120% of ideal value. Food was self selected with dietitian supervision, with or without the inclusion of the TakeShape, a Medifast brand modified fasting supplement.
>Read More...

*Savings based on average shipping costs. **If you are not satisfied with your results, for any reason, simply return your unused portion of the 4 week package within 30 days of purchase for a full refund. First-time customers only. †Offer valid for first time customers only and cannot be used in combination with any other promotions or discounts. Offer valid for a limited time only.